Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Pharmacology|January 1, 1981
Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluidP E Gormley, J H Wood, D G PoplackCancer Research|May 1, 1978
Interaction of 4'-(9-acridinylamino)methanesulfon-m-anisidide with DNA and inhibition of oncornavirus reverse transcriptase and cellular nucleic acid polymerasesP E Gormley, V S Sethi, R L CysykBiochemical and Biophysical Research Communications|October 31, 1983
An extremely potent anilinoacridine inhibitor of aldehyde oxidaseP E Gormley, E Rossitch, M E D'Anna, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)P E Gormley, D Gangji, J H Wood, et al.Clinical Pharmacology and Therapeutics|March 1, 1979
Kinetics of cis-dichlorodiammineplatinumP E Gormley, J M Bull, A F LeRoy, et al.Cancer Research|May 1, 1984
Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomesD D Shoemaker, R L Cysyk, P E Gormley, et al.Cancer Research|October 1, 1979
Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly scheduleD A Van Echo, D F Chiuten, P E Gormley, et al.Pageof 1